Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement
Provided By GlobeNewswire
Last update: Sep 26, 2025
CINCINNATI, OH & FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO), a commercial-stage biotechnology company focused on innovative solutions for men's health and oncology, and Ocuvex Therapeutics, Inc., a leader in ophthalmic innovation, today announced the mutual termination of their previously announced definitive merger agreement, dated July 16, 2025.
Read more at globenewswire.com
